Form 4: Phreesia SVP, Life Sciences, David Linetsky, Reports Stock Transactions

David Linetsky, SVP of Life Sciences at Phreesia, Inc., reports the acquisition of 53,990 restricted stock units and the indirect ownership of 8,851 common stock shares through a spouse.

Summary

• David Linetsky, Senior Vice President of Life Sciences at Phreesia, Inc., filed a Form 4 disclosing changes in his beneficial ownership of company stock.
• He acquired 53,990 restricted stock units (RSUs) on January 2, 2025, at a price of $0.
• These RSUs will vest over four years: 10% on January 2, 2026, 20% on January 2, 2027, 30% on January 2, 2028, and 40% on January 2, 2029, contingent on his continued employment.
• Linetsky also indirectly owns 8,851 shares of common stock through his spouse.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of stock transactions, which is generally neutral. The grant of RSUs is a positive sign of the company's commitment to its executives, but it's not a major event that would significantly impact sentiment.

Positives

• The grant of 53,990 RSUs to a key executive like David Linetsky indicates the company's commitment to retaining talent.
• The vesting schedule of the RSUs provides a long-term incentive for Linetsky to remain with the company.

Risks

• The vesting of the RSUs is contingent on Linetsky's continued employment, which introduces a risk of forfeiture if he leaves the company before the vesting dates.

Future Outlook

The document outlines the vesting schedule for the granted RSUs, which is contingent on the reporting person's continued service to the company.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the ownership structure and executive compensation practices.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as part of executive compensation is a common practice among publicly traded companies, particularly in the technology and healthcare sectors.
• Vesting schedules that extend over multiple years are also standard, designed to align executive interests with long-term company performance.
• Companies like Veeva Systems and Cerner Corporation also use similar equity-based compensation plans for their executives.

Stakeholder Impact

• The grant of RSUs to a key executive like David Linetsky can be seen as a positive sign by shareholders, indicating the company's commitment to retaining talent.
• The vesting schedule of the RSUs aligns the executive's interests with the long-term performance of the company, which is beneficial for shareholders.

Next Steps

• The vesting of the RSUs will occur over the next four years, contingent on David Linetsky's continued employment with Phreesia.

Key Dates

Keywords

Phreesia, David Linetsky, Restricted Stock Units, RSUs, Stock Ownership, Form 4, Insider Trading, Executive Compensation